Records containing: Stage IV Melanoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2017-05-24Radiation Use During Vemurafenib and Cobimetinib Treatment in Patients With BRAFV600 Mutated Stage IV or Unresectable Stage III Melanoma
-
CLINICAL_TRIALS study record update · 2017-04-19Laboratory-Treated T Cells and Ipilimumab in Treating Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2017-04-13FDG-PET/CT as a Biomarker for Treatment Response in Advanced Melanoma
-
CLINICAL_TRIALS study record update · 2017-02-15Phase I Study To Evaluate Cellular Adoptive Immunotherapy Using Autologous CD8+ Antigen-Specific T Cell Clones Following Cyclophosphamide Conditioning For Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2016-12-13Phase I/II Trial of the A-dmDT390-bisFv(UCHT1) Fusion Protein in Combination With Ionizing Radiation and Pembrolizumab for the Treatment of Stage IV Melanoma
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2016-12-08Evaluation of Disulfiram in Patients With Metastatic Melanoma and at Least One Prior Systemic Therapy, Phase I/II
-
CLINICAL_TRIALS study record update · 2016-10-10An Open-Label, Multicenter, Randomized, Phase Ib/II Study of E7080 (Lenvatinib) in Combination With Dacarbazine Versus Dacarbazine Alone as First Line Therapy in Patients With Stage IV Melanoma.
-
CLINICAL_TRIALS study record update · 2016-08-03A Phase 1/2 Study of SCH727965 in Patients With Malignant Melanoma
-
CLINICAL_TRIALS study record update · 2016-06-14Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma
-
CLINICAL_TRIALS study record update · 2016-05-30A Phase II Correlative Clinical Trial of MLN8237, a Selective Aurora Kinase A (AURKA) Inhibitor, in Patients With Unresectable Stage III or Stage IV Melanoma Disease
-
CLINICAL_TRIALS study record update · 2016-03-16An Open-Label, 2-Cohort, Multicenter, Phase 2 Study of E7080 (Lenvatinib) in Previously Treated Subjects With Unresectable Stage III or Stage IV Melanoma
-
CLINICAL_TRIALS study record update · 2015-10-06CD20-Immunotargeting in Metastatic Melanoma Patients- A Prospective, Open Label, Sequential Pilot Study
-
CLINICAL_TRIALS study record update · 2015-10-02Phase II Trial Of Interferon-B In Patients With Metastatic Cutaneous Melanoma And Metastatic Ocular Melanoma
-
CLINICAL_TRIALS study record update · 2015-07-23Isolated Limb Perfusion for Advanced Melanoma or Sarcoma Limited to Extremity With or Without Distant Metastases
-
CLINICAL_TRIALS study record update · 2015-06-23A Phase II Study of AZD2171 in Previously Untreated Patients With Metastatic or Recurrent Malignant Melanoma
-
CLINICAL_TRIALS study record update · 2015-04-15A Randomized Phase II Continuation Booster Trial After A Vaccine Combining Tyrosinase/GP100/Mart-1 Peptides Emulsified With Montanide ISA 51 and ISA 51 VG With Or Without GM-CSF For Patients With Resected Stages IIB/C, III And IV Melanoma
-
CLINICAL_TRIALS study record update · 2015-04-15Phase 2 Study of the Combination of BAY 43-9006 (Sorafenib) and CCI-779 (Temsirolimus) in Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2015-03-02A Phase II Study of UCN-01 in Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2015-02-04A Phase 2 Study Evaluating the Efficacy of VEGF Trap in Patients With Recurrent Inoperable Stage III or Stage IV Melanoma
-
CLINICAL_TRIALS study record update · 2014-12-23A Phase II Study of Imatinib Mesylate (STI571;NSC#716051:IND 61135) in Patients With Inoperable AJCC Stage III or IV Melanoma Harboring Somatic Alterations of C-KIT
-
CLINICAL_TRIALS study record update · 2014-10-03A Phase II Study of Vorinostat in Patients With Advanced Melanoma
-
CLINICAL_TRIALS study record update · 2014-09-25Phase I Dose Escalation of the MET Inhibitor XL184 and the BRAF Inhibitor Vemurafenib
-
CLINICAL_TRIALS study record update · 2014-06-18A Phase II Trial of MAP Kinase Inhibition With AZD6244 Hydrogen Sulfate in Combination With MK-2206 (Akt Inhibitor) in Patients With BRAF V600-Mutant Advanced Melanoma Whose Disease Has Progressed on Prior Therapy With a Selective BRAF Inhibitor (i.e., Vemurafenib, Dabrafenib, LGX818)
-
CLINICAL_TRIALS study record update · 2014-06-09Phase II Study of Intratumoral Injection of rF-TRICOMTM in Patients With Metastatic Melanoma Who Have Detectable Tumor Associated T Cells
-
CLINICAL_TRIALS study record update · 2014-05-22A PHASE II TRIAL OF A VACCINE COMBINING MULTIPLE CLASS I PEPTIDES WITH MONTANIDE ISA 51 OR ISA 51 VG AND CpG ADJUVANT 7909 FOR PATIENTS WITH RESECTED STAGES IIC/III AND IV MELANOMA